Johnson & Johnson sees highest patent filings and grants during August in Q3 2023
Johnson & Johnson saw the highest growth of 90% in patent filings and 137% in grants in August in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 87% and grants by 74%. GlobalData's DataBook provides a comprehensive analysis of Johnson & Johnson's patent filings and grants. Buy the databook here. Johnson & Johnson has been focused on protecting inventions in United States(US) with 793 publications in Q3 2023The United States(US) Patent Office dominates the patent filings and grants with nearly 27% filings and 41% grants. The United States(US), European Patent Office (E/P), China(CN), and World Intellectual Property Organization(WIPO) (WO) patent Office are among the top ten patent offices where Johnson & Johnson is filings its patents. Among the top granted patent authorities, Johnson & Johnson has 41% of its grants in United States(US), 26% in European Patent Office (E/P), and 8% in China(CN). Teleflex could be the strongest competitor for Johnson & JohnsonIn terms of grant share, Johnson & Johnson stands in one position among its competitors. Teleflex and Intuitive Surgical secured the top positions according to recent patent publication data. Patents related to healthtech and remote patient monitoring lead Johnson & Johnson's portfolioJohnson & Johnson has the highest number of patents in healthtech followed by, remote patient monitoring and smart hospitals. For healthtech, nearly 35% of patents were filed and 38% of patents were granted in Q3 2023. General surgery devices related patents lead Johnson & Johnson portfolio followed by orthopedic devices, and healthcare itJohnson & Johnson has highest number of patents in general surgery devices followed by orthopedic devices, healthcare it, diagnostic imaging and other remote patient monitoring. For general surgery devices, nearly 22% of patents were filed and 22% of patents were granted in Q3 2023. For comprehensive analysis of Johnson & Johnson's filings and grants, buy the databook here.
Access and buy GlobalData’s databook on the latest filings and grants activity for Johnson & Johnson here.
What's Your Reaction?
